Side-by-side comparison
MRK vs VRTX — Side-by-side comparison
MRK screens cheaper on EV/FCF, MRK has the higher ROIC, VRTX has grown revenue faster over five years, and Neither has the cleaner balance sheet by net debt / EBITDA.
MRK
Merck & Co.
Price
$122.41
Market cap
$208.5B
Day %
N/A
VRTX
VERTEX PHARMACEUTICALS INC / MA
Price
N/A
Market cap
N/A
Day %
N/A
MRK implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
15.7x
FCF yield
5.9%
5Y rev CAGR
9.4%
VRTX implied-growth snapshot
Simple static valuation context using owner earnings yield and realized growth.
EV/FCF
N/A
FCF yield
N/A
5Y rev CAGR
14.1%
5Y indexed stock chart
Static Recharts view indexed to 100 from available annual per-share data.
Quality Scorecard
Build-time composite score for MRK.
Grade C
57
/ 100
Quality Radar0 – 20 per axis
Quality Scorecard
Build-time composite score for VRTX.
Grade D
38
/ 100
Quality Radar0 – 20 per axis